Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1991-12-10
1993-08-24
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514866, A61K 31155
Patent
active
052389634
ABSTRACT:
The present invention relates to compositions and methods for inhibiting protein aging. Accordingly, a composition is disclosed which comprises an agent or compound capable of inhibiting the formation of advanced glycosylation end products of target proteins by reacting with the carbonyl moiety of the early glycosylation product of such target proteins formed by their initial glycosylation. Suitable agents may contain an active nitrogen-containing group, such as a hydrazine group. Particular agents comprise aminoguanidine, .alpha.-hydrazinohistidine and mixtures thereof. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be tre
REFERENCES:
patent: 4665192 (1987-05-01), Cerami
patent: 4758583 (1988-07-01), Cerami et al.
patent: 4978684 (1990-12-01), Cerami et al.
patent: 4983604 (1991-01-01), Ulrich et al.
Merck Index, 11th Ed., #453: Aminoguanidine (1989).
Carroll et al., Fed. Proc., 43(3), Abs. 2514 (1984), "Dose-Dependent Inhibition of Aortic Albumin Accumulation in Diabetes by a-Hydrazinohistidine."
Hollis et al., Exp. Mole. Path., 41, pp. 207-217 (1984), "Time-Dependent Changes in Aortic Albumin Permeability Characteristics in Experimental Diabetes".
Eble et al., J. Biol. Chem., 258(15), pp. 9406-9412 (1983), and Chem. Abs., 99, 99:84008P (1983), "Nonenzymatic Glucosylation and Glucose-dependent Cross-linking of Protein."
Hollis et al., Diabetologia, 28, pp. 282-295 (1985), "Inhibition of Aortic Histamine Synthesis by a-Hydrazinohistidine Inhibits Increased Aortic Albumin Accumulation in Experimental Diabetes in the Rat."
Hollis et al., Fed. Proc., 43(3), Abs. 2513 (1984), "Aortic Albumin Accumulation in Diabetes and Hypertension and its Alteration by a-Hydrazinohistidine, insulin, and hypertension Reversal."
Hollis et al., Exp. Mole. Path., 43, pp. 90-96 (1985), "Changes in Plasma Histamine Concentration in the Streptozotocin-Diabetic Rat."
Lindberg et al., Acta Obst. Gyn, Scandianav, 45, pp. 131-139 (1966), "The Inhibitory Effect of Aminoguanidine on Histamine Catabolism in Human Pregnancy".
Monnier et al., Science, 211, pp. 491-493 (1981), "Nonenzymatic Browning In Vivo: Possible Process for Aging of Long-Lived Proteins."
Orlidge et al., Arteriosclerosis, 2(2), pp. 142-150 (1982), "Aortic Endothelial and Smooth Muscle Histamine Metabolism in Experimental Diabetes."
Owens et al., Arteriosclerosis, 1(4), pp. 265-272 (1981), "Local Aortic Histamine Metabolism and Albumin Accumulation."
Brownlee et al., Science, 232, pp. 1629-1632 (1986), "Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking."
Brownlee et al., Diabetes, 35, Supp. 1, pp. 42A (1986), "Inhibition of Glucose-derived Protein Cross-linking and Prevention of Early Diabetic Changes in Glomerular Basement Membrane by Aminoguanidine."
Brownlee et al., J. Exp. Med., 158, pp. 1739-1744 (1983), "Covalent Attachment of Soluble Proteins by Nonenzymatically Glycosylated Collagen."
Brownlee et al., Ann. Int. Med., 101(4), pp. 527-537 (1984), "Nonenzymatic Glycosylation and the Pathogenesis of Diabetic Complications."
The Merck Index, 6th Edition, p. 60 (1976).
Brownlee Michael
Cerami Anthony
Ulrich Peter C.
Jordan Kimberly R.
The Rockefeller University
Waddell Frederick E.
LandOfFree
Method and agents for inhibiting protein aging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and agents for inhibiting protein aging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and agents for inhibiting protein aging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-829568